[Sodium dantrolene].
D000284:Administration, Oral; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology; D003620:Dantrolene / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004341:Drug Evaluation; D006321:Heart / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D008305:Malignant Hyperthermia / Q000188:drug therapy*; D009119:Muscle Contraction / Q000187:drug effects; D011229:Preanesthetic Medication; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism
D002121:Calcium Channel Blockers; D003620:Dantrolene; D002118:Calcium
Dantroleno sódico.